There were 818 press releases posted in the last 24 hours and 183,880 in the last 365 days.

Dermatological Drugs Market worth US$44.68 billion by 2031. Visiongain Research Inc.

/EIN News/ -- Global Dermatological Drugs Market Forecast 2021-2031: By Disease (Psoriasis, Dermatitis, Acne, Skin Infections, Other Diseases) By Skin Infections Drugs (Bepanthen/Bepanthol, Protopic, Dermovate) By Psoriasis Drugs (Humira, Stelara, Enbrel, Remicade, Taltz, Otezla) By Dermatitis Drugs (Cubicin, Zyvox, Valtrex, Canesten, Lamisil, Other Dermatitis Drugs) Route of Administration (Topical, Oral, Parenteral Administration) Plus analysis of leading regional/national markets and leading companies in the market. COVID-19 Impact Recovery Analysis (V-shaped recovery, W-shaped recovery, U-shaped recovery, L-shaped recovery)

Download Exclusive Sample of Report @

Key Questions Answered by this Report:
• What is the current size of the overall global dermatological drugs market? How much will this market be worth from 2021 to 2031?
• What are the main drivers and restraints that will shape the overall dermatological drugs market over the next ten years?
• What are the main segments within the overall dermatological drugs market?
• How much will each of these segments be worth for the period 2021 to 2031?
• How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world dermatological drugs?
• What is their status and how will they develop over the next ten years?
• What are their revenue potentials to 2031?
• How will political and regulatory forces influence regional markets?
• How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
• Who are the leading companies and what are their activities, results, developments, and prospects?
• What are the leading dermatological drugs? What are their revenues and latest developments?
• What are some of the most prominent human dermatological drugs currently in development?
• What are the main trends that will affect the world dermatological drugs market between 2021 and 2031?
• What are the social, technological, economic and political influences that will shape that industry over the next ten years?
• How will the global dermatological drugs market evolve over the forecasted period, 2021 to 2031?
• Which drugs can succeed and what revenues could they generate to 2031?
• What will be the main commercial drivers for the market from 2021 to 2031?
• How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?
• How will that industry evolve between 2021 and 2031, especially in R&D?

Which Key Players are leading the Global Market and how much Share do they hold?
The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap into the opportunities that this market offers. Companies are trying to explore the available prospects by adopting various strategies such as:

  • Mergers and Acquisitions activities.
  • Product launches.
  • Collaborations and Partnerships.

Product approval is a major milestone facing all key competitors in the dermatological drugs market. Several strategies were implemented by key market players between 2015 and Jan 2021.

Get Detailed TOC @

Discover sales predictions for the global dermatological drugs market and submarkets.
Along with revenue prediction for the overall world market, there are 5 segmentations of the dermatological drugs market, with forecasts for 5 disease type, 3 Skin Infections, 6 Psoriasis Drugs, 4 Product search forecasted at a global, regional, and country level, along with COVID-19 impact recovery pattern analysis for all segments.

Leading companies and the potential for market growth
Visiongain’s lead analyst says: ‘  global dermatological drugs market is estimated to be valued at US$24.7 billion in 2021 and is projected to reach at a market value of US$44.68 billion by 2031. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead’.

Why should you read this report?
The report study aims to explore the market drivers, restraints and market opportunities facing dermatological drugs product stakeholders in different geographic areas. Also, it identifies trends, gaps, and opportunities in each micro market segment. Finally, this report identifies the major stakeholders, product portfolios, and recent developments to help draw a competitive landscape for players in this market.

Leading Players in the Market

  • AbbVie Inc. (AbbVie)
  • Abbott Laboratories
  • Bayer Pharmaceuticals
  • Bristol-Myers Squibb
  • Cadila Healthcare
  • Cipla
  • Dr Reddy’s
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals Limited
  • L’Oreal SA
  • Lupin Limited
  • Pfizer Inc. (Pfizer)
  • Merck Group Chemicals
  • Sun Pharma
  • Taro Pharmaceutical Industries Ltd
  • Johnson & Johnson Inc.
  • Roche Holding AG (Roche)
  • Sun Pharmaceutical Industries Limited
  • Sanofi Pasteur Pharmaceutical
  • Takeda Pharmaceutical Company Limited
  • Taro Pharmaceutical Industries Ltd. (Taro)

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Find more research reports on the Drugs Industry, please click on the following links: 

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

About Visiongain
Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports means that you can have a bespoke piece of market intelligence customized to your very own business needs.

Sara Peerun
Commercial Director
Visiongain Inc.
Tel: + 44 207 549 9987
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Follow Us: LinkedIn | Twitter
SOURCE Visiongain Limited.

Primary Logo